tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ETNB Stock Latest News

89bio price target lowered to $30 from $31 at BofA
The Fly89bio price target lowered to $30 from $31 at BofA
14h ago
ETNB
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
4d ago
CVM
TIL
89bio Inc. Reports Q1 2025 Financial Results
PremiumCompany Announcements
89bio Inc. Reports Q1 2025 Financial Results
22d ago
ETNB
89bio’s Strong Position and Promising Outlook in Biopharmaceutical Sector with Pegozafermin Advancements
PremiumRatings
89bio’s Strong Position and Promising Outlook in Biopharmaceutical Sector with Pegozafermin Advancements
23d ago
ETNB
89bio reports Q1 EPS (49c), consensus (57c)
PremiumThe Fly
89bio reports Q1 EPS (49c), consensus (57c)
26d ago
ETNB
89bio assumed with an Overweight at Cantor Fitzgerald
PremiumThe Fly89bio assumed with an Overweight at Cantor Fitzgerald
28d ago
AKRO
ETNB
89bio Updates on Pegozafermin Clinical Progress
Premium
Company Announcements
89bio Updates on Pegozafermin Clinical Progress
2M ago
8K
ETNB
89bio initiated with a Neutral at Goldman Sachs
Premium
The Fly
89bio initiated with a Neutral at Goldman Sachs
2M ago
ETNB
89bio initiated with a Buy at Citi
PremiumThe Fly
89bio initiated with a Buy at Citi
3M ago
ETNB
89Bio Inc. Faces Financial Risks Amid Market Challenges for Approved Products
PremiumCompany Announcements
89Bio Inc. Faces Financial Risks Amid Market Challenges for Approved Products
3M ago
ETNB
89bio Inc. Advances Clinical Trials Amid Financial Losses
PremiumCompany Announcements
89bio Inc. Advances Clinical Trials Amid Financial Losses
3M ago
ETNB
89bio price target lowered to $21 from $29 at H.C. Wainwright
PremiumThe Fly
89bio price target lowered to $21 from $29 at H.C. Wainwright
3M ago
ETNB
89bio reports Q4 EPS ($1.02), consensus (76c)
PremiumThe Fly89bio reports Q4 EPS ($1.02), consensus (76c)
3M ago
ETNB
ETNB Insider Trade Alert! Majority Shareholder Buys $50M Worth of 89bio Stock
Premium
Market News
ETNB Insider Trade Alert! Majority Shareholder Buys $50M Worth of 89bio Stock
4M ago
ETNB
3 Best Stocks to Buy Now, 2/4/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 2/4/2025, According to Top Analysts
4M ago
CVRX
ETNB
89bio Stock Upgraded to Buy: Positive SYMMETRY Study Data Reinforces FGF21 Analog Potential
PremiumRatings
89bio Stock Upgraded to Buy: Positive SYMMETRY Study Data Reinforces FGF21 Analog Potential
4M ago
ETNB
89bio initiated with an Outperform at Wolfe Research
PremiumThe Fly
89bio initiated with an Outperform at Wolfe Research
4M ago
AKRO
ETNB
89bio initiated with an Outperform at Wolfe Research
PremiumThe Fly
89bio initiated with an Outperform at Wolfe Research
4M ago
ETNB
89bio price target raised to $38 from $25 at UBS, says shares ‘undervalued’
PremiumThe Fly
89bio price target raised to $38 from $25 at UBS, says shares ‘undervalued’
4M ago
AKRO
ETNB
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
4M ago
AKRO
ALLK
Akero upgraded to Buy at BofA after ‘transformative’ liver data
Premium
The Fly
Akero upgraded to Buy at BofA after ‘transformative’ liver data
4M ago
AKRO
ETNB
89bio price target raised to $34 from $30 at BofA
Premium
The Fly
89bio price target raised to $34 from $30 at BofA
4M ago
ETNB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >